Mentions
Extended reach
Total likes
Video views
AI synopsis
In the discussions about the publication, many users cite specific data points such as the mention of 'no serious vaccine-related adverse events' and the comparison of immune responses between adolescents and young adults. Statements like 'the immune response is even stronger' suggest enthusiasm and confidence in vaccine efficacy, while others question the study's integrity with phrases like 'a blatant lie' regarding reported adverse events. These varied tones reflect both a willingness to accept the findings and a significant skepticism that informs the broader conversation on vaccine safety among adolescents.
Many discussions highlight agreement on the general positive findings regarding vaccine safety and efficacy, though some express skepticism.
The volume of discussions showcases a high level of curiosity about the vaccine's impact on adolescents, with users frequently seeking out and sharing detailed data.
Some posts delve into the methodology of the clinical trials and the implications of the findings, reflecting a moderate level of engagement.
A strong belief emerges that the publication could significantly influence vaccine policies and public health measures for adolescents.
3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and contribute to herd immunity.“ Die Autoren von #Pfizer/#BioNTech suggerierten hier also tatsächlich, man bräuchte die #Impfung … https://t.co/FFmWgfYNN4
O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e poucos eventos adversos sérios em geral.” Isso é uma mentira descarada . https://t.co/h06EAzK2D7 Mas o NEJM não vai retratar o artigo apesar da prova https://t.co/mRv8XkR8Lz
Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescents. https://t.co/vuGgy5pQbA https://t.co/sVgCsXixp6 Meanwhile, hospitalization of children due to COVID is rising significantly. https://t.co/bhM3ssLjPO https://t.co/6m9YhrFf9i
Los resultados de los ensayos de Pfizer-Biontech para mayores de 12 años se pueden leer en https://t.co/dQXY2gWDXU. Un reciente comunicado de prensa del laboratorio asegura que también es segura para niñes de 5 a 12 años: https://t.co/jjAftduiLZ
15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las vacunas en adolescentes. (https://t.co/XPySexlaCc). Excluyeron aquellos con problemas de salud, alergias a vacunas, y los expuestos al virus. ¿Entonces?
@klshw @MadaGadol אבל פתאום חשבתי שלמה שלא נפרגן לענקי המדע האלה, אז הנה @MadaGadol הניסוי הקליני שנערך בבני 5-11 וגם זה שנערך בבני 12-15, אם תוכלו להכווין לנקודה שבה חיסון פייזר הוכיח מניעת הדבקה או מניעת מחלה קשה בילדים https://t.co/C8eLsmpWo8 https://t.co/Foijc1l8Uc
This video explores the safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents aged 12 to 15. Join us as we discuss findings from a clinical trial that demonstrated comparable immune…
This video explains the Pfizer BioNTech COVID-19 vaccine, highlighting its safety and efficacy, especially in adolescents aged 12 to 15. Learn about the clinical trial results, including mild side effects and the robust…
@UnderBismuth @MdBreathe Here ya go lazy bones https://t.co/srBs7TRaos
@minamiyoro @goodluck1185 その2 https://t.co/ICiKWsMzIX
@6fores1 @StoryBeats @MikebertPhD @drdrew Here's #8: https://t.co/4DW8McEmxU
@6fores1 @StoryBeats @MikebertPhD @drdrew Here's another one, pre-licensure, saline placebo, safety analysis: https://t.co/4DW8McEmxU
@Roberto2030Nao @AguiarGardene @karinamichelin Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents | New England Journal of Medicine
RT @IntegralAnswers: 11/ Ages 12–15
11/ Ages 12–15
@FreeMIN24465256 @BenoitWari @Nemausus1 Tu peux répéter qu'il y a UNE SEULE étude de Pfizer qui teste la sécurité de ses vaccins s'il te plaît? https://t.co/NIEeFDpUy0 https://t.co/tXWdwDb5Sb https://t.co/fxDcnibpwZ Je suis déjà à 5 articles publiés par le labo. Tu ne vas pas être de mauvaise foi hein ?
@BaehlerEric @ChomskyChannel @tentotheeighth @DrNeilStone We can move the goal post- that’s fine. https://t.co/qhoilaoRFz https://t.co/jXFYQz08IB https://t.co/T5QNFlrL8a I can send more, but these are the pivotal ones especially early on. These ones also have IS separated from observations, which is ideal to minimize bias.
@Logos_siochain @meokater @littlewisehen @grok 17. Dagan et al., 2021 https://t.co/ayL0U6GRXK 18. El Sahly et al., 2021 https://t.co/tk3yxy3Eye 19. Frenck et al., 2021 https://t.co/jukgMGSa3p 20. Glanville et al., 2022 https://t.co/Dnt9otLbKG
Frenck et al. (2021) is the trial @shdegaray73's children were in - her family made up 1 in 1,130 of the participants (0.09%). Yet, her daughter's injuries don't get a single mention in Frenck et al. (2021). https://t.co/4kfTaWtCua That was a major "omission" by Frenck et al.
@WaltTkaczuk @HilaryWollis @MaryLTrump 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@kerry_echo @RenzTom @truplistic 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Plshelton1959 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@megababe73 @Crash_the_Flash @SenWarren 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@G8TR1994 @SaltyGoat17 @SenWarren 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@TerryHaffnerMD @mgtruth @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Stacy_CAWMP @JacobXingBlog @EricLDaugh 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@DonaldWShimoda @leenan05738343 @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Net_Inquisitor @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@TheReal_RayWay @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@BrownstoneSteve @carolynmrsE62 @SydneyAnneToo @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Lfthndjoshua @PatrioticPizzas @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@delboy1978uk @bttldog @drstaceybutters @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@backwoodsohm @FiveTimesAugust @hwinkler4real 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@john_stelios @BenGHealey @drstaceybutters @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@RWTNews @JRamboCap1 @theliamnissan 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@CanadianAthies1 @Beachtime2023 @IanCopeland5 @rohangilkes 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@ShaunHensleyCA @RichardMccrar20 @DawnsMission 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@RichardMccrar20 @DawnsMission 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@SquabOnTheCob @aintscarylarry 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
RT @IceSohei: O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e po…
O artigo fraudulento ainda é publicado no NEJM . O artigo diz: “não houve eventos adversos sérios relacionados à vacina e poucos eventos adversos sérios em geral.” Isso é uma mentira descarada . https://t.co/h06EAzK2D7 Mas o NEJM não vai retratar o artigo apesar da prova https://t.co/mRv8XkR8Lz
@drbarrymarks @DrBenTapper1 @ChildrensHD 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@bev_mcmullan @toobaffled 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
➡️2/n Weitere Studien zu Effektivität & Sicherheit der #COVID-Impfung für Kinder: https://t.co/TilNrlvi5Q https://t.co/QklwbmkpCS https://t.co/VneGcsnXuJ https://t.co/XdLxdgCB6n https://t.co/rPqYWPL4oN https://t.co/SzotyQEyMo EMA hat die Vakzine für Kinder authorisiert.⬇️ https://t.co/iOJGzqSzaR
@MichaelTW87 @uk_sf_writer @TonyHinton2016 @CathyMo41926708 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@CathyMo41926708 @uk_sf_writer @TonyHinton2016 @ABridgen 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@caseypostelman1 @JeckovKanani 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@publis91388 @MichaelSil59673 @JoJoFromJerz 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@theAwakened1_ @FGoldwyn @DisavowTrump20 @RepLaurelLee 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Spaceface1990 @rickpittman532 @MDKramer01 @NBassgrl @prolibshow 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@MDKramer01 @rickpittman532 @NBassgrl @prolibshow 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@GusFlory @W92Baj @Charmer184 @BGatesIsaPyscho 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@labsarekindest @JohnMartin1975 @Toy_Room @BrentLeeSDCIC Bro I google searched your exact reference and selected the link.
@tomasdorph @JohnMartin1975 @Toy_Room @BrentLeeSDCIC 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@shireen_jones @AndyGJBurge @ABridgen 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@DumbocratD @RyanMarino @JB_24816 @ThomasCrout 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@FawkesRevive @MissHot @MTnutz @dr_kkjetelina 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@MeeshFL @dr_kkjetelina @AaronSiriSG 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@greygirl2023 @MeeshFL @dr_kkjetelina 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@kikastra @claes69 @RaisedRightDay1 @DefiantLs 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@BryanLand111980 @wcgrimley @kerpen @JesseMatchey https://t.co/gqQ5X1Qmhx
@DanWebber810092 @IncJazzo @sjs856 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@SeptembersRain @twgurl54 @VigilantFox 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@BringBackBryzzo @D4rk_n3ws @VigilantFox 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@BobRoss54314105 @Skypso1 @HilaryGeraghty @Mainly_Aiming @liz_churchill10 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@DannyGaytant @PinarellokeP @HansLandman @mariannezw Als ik je een link stuur naar een wetenschappelijke publicatie van de trial onder 12 tot 15-jarigen, moet je niet beweren dat ze niet op die leeftijd zijn getest. Of gaat het je niet om feiten, maar zanik je om te compenseren voor je te kleine piemeltje? https://t.co/nPKNiw7AAs
@DannyGaytant @HansLandman @mariannezw Ooit gehoord van zelf onderzoek doen? Moet alles je voorgekauwd worden? Nou, hier een begin: https://t.co/nPKNiw7AAs
@picker_six1253 @AndyGJBurge @ABridgen 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@RepThomasMassie @c_essene 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@zormie @FiveTimesAugust @johncusack 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@zormie @FiveTimesAugust @johncusack 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@JeremyFoub @ChatSecouriste @TakJalanKaki @TheObserver1901 @TOUKO91923804 @annecy_photos @raoult_didier Ci-joint le "sans donnée fabricant sur cette classe d'âge... " https://t.co/A64BeivrsL
@JeremyFoub @TakJalanKaki @ChatSecouriste @TheObserver1901 @TOUKO91923804 @annecy_photos @raoult_didier Ci-joint "l'aucune étude concernant leur classe d'âge " : https://t.co/A64BeivrsL
@JeremyFoub @TakJalanKaki @ChatSecouriste @TheObserver1901 @TOUKO91923804 @annecy_photos @raoult_didier Ci-joint l'étude du fabricant sur cette classe d'âge qui n'existe pas : https://t.co/A64BeivrsL
@JeremyFoub @TakJalanKaki @ChatSecouriste @TheObserver1901 @TOUKO91923804 @annecy_photos @raoult_didier Ci-joint la fameuse étude du fabricant qui n'existe pas : https://t.co/A64BeivrsL
@JeremyFoub @TakJalanKaki @ChatSecouriste @TheObserver1901 @TOUKO91923804 @annecy_photos @raoult_didier Prouve que cet article scientifique n'existe pas https://t.co/A64BeivrsL
@JeremyFoub @TakJalanKaki @ChatSecouriste @TheObserver1901 @TOUKO91923804 @annecy_photos @raoult_didier C'est ta question qui est à côté. Il y a des données solides et fiables sur la sécurité et l'efficacité du vaccin de Pfizer chez les moins de 16 ans : https://t.co/A64BeivZij
@JeremyFoub @ChatSecouriste @GValeau @TheObserver1901 @TOUKO91923804 @annecy_photos @raoult_didier https://t.co/CxuzRRxYA5 https://t.co/s56i7VnfNQ
@Stoic1Yrkoon9 @dr_andrealove @WIRED 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Runningmansuzie @judysimpson222 @morphnz68 @M_a_r_o_n_DK Oh wait, I forgot a few more
@epigeneticallyj @saltbeefsandwch @BurgerLab12 @sduncanhealth @TonyBaduy @PickEmLegend @market_memetics @PlatoonOps @charlespinion @mcfunny @JimeeLiberty @J91U17 @jilel76 @SolleyButler @Mike61508177700 @FitnessApple106 @Agent2Dark @dirk_fasshauer @HossmanOfficial @ogilville1 @swords_mr @karleastlondon @lavalmxhr @ckellywpg @ASchifty @zee_parody @Scary7Dr @IckeExposed @ValZimmer2 @KuikenAndrew @cbeckj @nuhope2022 @Pouldeau61 @KinseyKat1 @nickowe49445250 @VickiCoyle10019 @doom37455413 @RealJonTSmith @TheeLoneGunmen @orwelleye @richykirsh @JKelleyK @villagerssn @NexusSwords @ScooterScience @JordanScottish @IndyTim40 @eanstrainserver @lazlowoodbine42 That's rubbish. None died. That's ZERO deaths in 2260 participants. No thromboses, no hypersensitivity, no vaccine anaphylaxis either. One placebo recipient got appendicitis
@BaronRais How many articles do you want? 1- https://t.co/OVRkSHwrrT 2- https://t.co/SC4a1HG2g4 3- https://t.co/FMLCYMXijr 4 - https://t.co/OVRkSHwrrT 5- https://t.co/Ua03QWcYqO 6- https://t.co/whJZWNKRT5 7- https://t.co/gWVfFak2at
@AblemanAdam @Debunk_the_Funk Even if they did initially, they DID follow up as stated in their study. "Few participants in any cohort (≤0.4% through 1 month after dose 2) had serious adverse events, and none were considered by the investigators to have been vaccine-related." https://t.co/MMVwGcDqG2
@TimB2101 @tuxzito12345 @youknow714 @PistonsLuvr @8BrianVogel4 @Sasquatch4eva @astragal @IamJesusLickme @FireBidenNow @MoMothra54 @dulcieburt @GThonks @OriginalGoalie @9teen80four @TyefiaM @TShadowKnow @John1800Blair @NumbersMean @FrankGeurts3 @hellosf77 @HamRadioJoe @CampTerrence @Julie_NoNumbers @AngryFleas @saltbeefsandwch @Blueresin1 @Murphys2ndLaw @TBD77 @VinceGottalotta @4horseshoesbw @tkitts54 @Doubting_1 @kentlee47 @TheLandomatic @DumaineJaquette @GSyslo @Ajohnso50141696 @BconnectedJ @lavenlarose @ScootyPuffSr99 @BillParanoia @MAGA_Translator @NoNoNameAnon @rocktobyte @SidneyPowell1 @JennaEllisEsq @RudyGiuliani @RogerJStoneJr @RepMTG How did the company know their claims were not factual, when those claims were based on the Clinical Study undertaken? https://t.co/6FBzscEvNN https://t.co/waoXErpici
@momentomoriDM @theCorravalis @SARS2Creator @ModelAyshaMirza @PeterHotez 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@theCorravalis @SARS2Creator @momentomoriDM @ModelAyshaMirza @PeterHotez 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@SARS2Creator @mindyouropening @ModelAyshaMirza @PeterHotez 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@SageblogOrg @PastorAlTaco @EJohns03 @NicoleShanahan 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Caino37234468 @comeonyouyellow @yay_its_james @boorad1234 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Mike61508177700 @desktopcarl @Boris4T @DaveAnotherdave @18DellaLia37961 @PavlosPavlova @xyzfredsmith @jneill @TruthHurts2160 @Alex_on_A14 @TheeLoneGunmen @MiniJet10 @GeneralWynne @sayantoken @judysimpson222 @Imonlyslightly @WiserWench @k_b_lvi @STEWIEGRIFTING @tulloch1978 @SaraCompton776 @my_own_RESEARCH Did you not comprehend what this is? It’s from the FDA document referenced in your proof that you are sorely lacking in knowledge. https://t.co/gTjHCRcnCS
@Mike61508177700 @desktopcarl @Boris4T @DaveAnotherdave @18DellaLia37961 @PavlosPavlova @xyzfredsmith @jneill @TruthHurts2160 @Alex_on_A14 @TheeLoneGunmen @MiniJet10 @GeneralWynne @sayantoken @judysimpson222 @Imonlyslightly @WiserWench @k_b_lvi @STEWIEGRIFTING @tulloch1978 @SaraCompton776 @my_own_RESEARCH Pain at the injection site. Yep, 86% did suffers sore arm. https://t.co/gTjHCRcnCS https://t.co/q0kwO9KguV
@Kevin_McKernan @CrostyGa @JesslovesMJK 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@gerdantes Doch, natürlich
@HilldurG @MarkWar16520311 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@derowzey @YouWhat1715936 @yay_its_james 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@curosant41471 @jmedwardsdc @minagelina1 @stkirsch 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@KarlaODell11 @scottbuzzer @LegalizeItLala_ 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@freegazanias @AVorticVertere @RBystrianyk 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@ShifftyAdam @Nehemiah490 @sjs856 @FiveTimesAugust 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@sudsy5830 @SuzieQT11 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Nehemiah490 @sjs856 @FiveTimesAugust 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@STORMANGEL777 @SuzieQT11 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@MEMECOINCHAD @sjs856 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@HamHead5813 @sjs856 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@KootsIslander @sjs856 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@JosephAFetz @Kevin_McKernan 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@seswope @shangrila500 @Kevin_McKernan 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@TrueBlue_76 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@UnMaskd_Truth @CBoy287 @VPrasadMDMPH 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@MeliR143 @rubrogram @eekymom 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@vancemurphy 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@DrewBat @JohntheLyricist 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@SAntiochis @USMortality @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@GenFlynn @FiveTimesAugust 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
The paper says: “there were no vaccine-related serious adverse events and few overall severe adverse events.” That’s a blatant LIE! Despite the clear proof of scientific fraud, because that’s the way science works… https://t.co/wRWpyqKqxT
@iamdjanggo_ @GhostofBPH 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@jimmyfra88 @GoCats1982 @Heretic_555666 @KevinJa52749283 @MattAttack009_ 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@End_thetyranny @Awithonelison 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Gandalf_Rules @IanCopeland5 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@RenzTom @browt1971 @realDonaldTrump 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@CathabelR @USMortality @IanCopeland5 https://t.co/f6kRWBzngR
@TheCIVICSc @JohntheLyricist 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@OrganicHippyVan @KLVeritas @naomirwolf @chiproytx @DeptofDefense 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@OlooneyJohn 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@dawnCJ100 @FiveTimesAugust 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@GeneralRipper22 @IanCopeland5 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@jeanbarbeau2 @C_Classiques Ref - for bookmark https://t.co/qWxn3CCWLt
@Intensteve1 @DrPuerner 12-15 als Alter: https://t.co/X3dYxfuscM
@DrTahoeMD @GetSchwifyinere @OccamsHO0U812 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@genericeddie @DocDeezWhat Erm https://t.co/T2DbxKtM5R https://t.co/XKHlbaWN34 https://t.co/nxVDb200K3 https://t.co/O6IjYejRrw https://t.co/DdWWSdDyJ2 https://t.co/73iumx8zO7
@inQistveStephen @BroccoliStrong @IanCopeland5 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Protagonisthell @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@notabotautobot @DrNeilStone 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@GolfElkLife @jimeekay @The_JAY_N_G @DrSusanOliver1 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@GolfElkLife @jimeekay @The_JAY_N_G @DrSusanOliver1 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@drsimonegold 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@More_Plato @thereal81233611 @rohangilkes @IanCopeland5 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Notasheeple52 @stkirsch @IanCopeland5 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@AndrejTaz @StaunchOrange @LarryGreer20 @IanCopeland5 @TuckerCarlson @stkirsch 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@PamelaCreel5 @dogmomjenn 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@Gandalf_Rules @PJ671 @GetSchwifyinere @TuckerCarlson @stkirsch 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@morenol_1990 Links from page one of the adolescent study. Proof all links are real on all my data. I also have screenshots. Do better https://t.co/WBAtoIn6Dy https://t.co/4zaW6TlXex https://t.co/vIqaP6DU7z https://t.co/R75tIoflYJ https://t.co/RQqACOjrMb https://t.co/zr59QcP5hl https://t.co/620xz3OBzR
@critkalthinker @rohangilkes @seamulemud @IanCopeland5 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@James103922864 @thebryanmadigan @BradHazzard 1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med 2021; 385:239.
@RenatoSNog @Rodrigo61192299 kkkkkkkk! Caíste no conto dos negacionistas. E eu te provo com o estudo abaixo num dos principais periódicos científicos do mundo. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents https://t.co/Qo6aDO9Mtz
@andreac_duar Não, se soubesse mesmo como são feitas não estaria falado uma asneira dessas. Acorde fia e peça, caso não saiba inglês, para alguém te ler o estudo abaixo. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents https://t.co/Qo6aDO9Mtz
@helendiniz20 Na sua bio diz que és formada em ciências biológicas. Como, tendo uma formação dessas, vc vai ser anti-vacina???? Pegue os estudos publicados na JAMA, na BMJ, na Nature, estudos duplo-cegos, não há como ser contra essa vacina se vc ler esses estudos. https://t.co/dqxjnbIff3
@MGermaine6 @xyzfredsmith @judysimpson222 @pondlifetwit @JohnGHart @AntityrantGB @VickiCoyle10019 @ColinASylvester @JuliaHadley15 @thegistofitis @thisisnothappen @BreezerGalway @jesuslysses @John_P_Topham @axoplasmicgap @ABridgen https://t.co/T2DbxKujVp https://t.co/XKHlbaXkSC https://t.co/nxVDb20yzB https://t.co/O6IjYekph4 https://t.co/DdWWSdE6yA https://t.co/73iumx97DF 4/
@American_Kopite @STRAT777 @Graham_Wharton @stkirsch Here you go, dipshit: https://t.co/EDeYdsWDfQ
4520 parents submitted their 12 to 15 year old children for an experimental trial of the Pfizer mRNA treatment (proof below). Some of them are now suing Pfizer for vaccine harms. But who the hell signs their children up for pharma trials? I don't get it. https://t.co/yj0kWrKnr2
@Horatioyuletide @NewMumOnline @dbdegn @ProfKarolSikora Surely you can find the clinical trials for adolescents without my help? https://t.co/F0dN5Blnpe
@JLangWood Get fucked. This was her trial. https://t.co/M0qIMdCebM And change your profile photo
@plus_eins_plus @DrPuerner Verzapf' keinen Bullshit *omg https://t.co/f4rawNwzy0 https://t.co/mTO3yTVQtA
@Water_juffer @BladiYath @HZwartemeer Hier: https://t.co/UwmuwnJmLn En hier: https://t.co/f5nuBsDKaX Dus was het in eerste instantie ook alleen goedgekeurd voor volwassen, wat pas werd uitgebreid voor kinderen NA deze studies. Helder?
@ImmortelleXIII @yves_lol @baltringos @JeanYvesCAPO @raoult_didier C'est pourtant pas compliqué à trouver : https://t.co/ETWEhHtO1X
@mpc_xetts @RobinReichman1 @Humanlty1o1 https://t.co/xrU7tFNSiI
@thatsnotmine125 Here are Pfizer MS for 5-11 and 12-17 - It doesn’t appear that they released baseline health details for kids like they did for adults https://t.co/0xBAumqJXH https://t.co/Ql5HKXDmKN
@StabellBenn Why do the 6 peer reviewed papers you used for your preprint not agree with your opinions? 1/Frenk et al 'Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents" https://t.co/4WkM9u7IrB https://t.co/A8VavtBB6Q
@Sophie14600436 @silvano_trotta @YvesPDB Vous me faites rire bot14600436 Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents https://t.co/15j8toLWV6 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine https://t.co/PENgUYclcE
RT @EpochTimes: https://t.co/lyiVaXMV4K Between those meetings, the #FDA expanded access to Pfizer's vaccine to those aged 12–15 based on d…
RT @EpochTimes: https://t.co/lyiVaXMV4K Between those meetings, the #FDA expanded access to Pfizer's vaccine to those aged 12–15 based on d…
RT @EpochTimes: https://t.co/lyiVaXMV4K Between those meetings, the #FDA expanded access to Pfizer's vaccine to those aged 12–15 based on d…
RT @EpochTimes: https://t.co/lyiVaXMV4K Between those meetings, the #FDA expanded access to Pfizer's vaccine to those aged 12–15 based on d…
RT @EpochTimes: https://t.co/lyiVaXMV4K Between those meetings, the #FDA expanded access to Pfizer's vaccine to those aged 12–15 based on d…
https://t.co/lyiVaXMV4K Between those meetings, the #FDA expanded access to Pfizer's vaccine to those aged 12–15 based on data from a trial in which 1,131 adolescents received the vaccine and none died or experienced #Myocarditis. Dr. Walensky recommended the age group receive
@JerylBier @IUPswack @CathyYoung63 It means that people are likely to feel crumby or have a fever after a vaccine. Is this news to you? https://t.co/xBJhRF1Hj3 https://t.co/MaUUqfjAZ6
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @labezivon: @Zero_Long_Covid
@Zero_Long_Covid
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
@KaiserCut @SHomburg unter diesem gesichtspunkt ist die studie zur kinderplörre besonders spannend allein bei erhöhter IKT (> 38°C) gab es mehr fälle in der verum gruppe als in der placebogruppe 192/226 fälle verum vs. 16 fälle placebo https://t.co/cwVd3D360w
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
@IamBrookJackson Re: BNT162b2. "[T]here were no vaccine-related serious adverse events....". Then who is Maddie De Garay? ( https://t.co/4JupM2BZSn ) https://t.co/KBsXLa7P8C https://t.co/E7HaB6jjp5
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
RT @Quo_vadis_BRD: 3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and…
3/ „Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socialization, and contribute to herd immunity.“ Die Autoren von #Pfizer/#BioNTech suggerierten hier also tatsächlich, man bräuchte die #Impfung … https://t.co/FFmWgfYNN4
RT @Logan5__: @klshw @MadaGadol אבל פתאום חשבתי שלמה שלא נפרגן לענקי המדע האלה, אז הנה @MadaGadol הניסוי הקליני שנערך בבני 5-11 וגם זה שנע…
@klshw @MadaGadol אבל פתאום חשבתי שלמה שלא נפרגן לענקי המדע האלה, אז הנה @MadaGadol הניסוי הקליני שנערך בבני 5-11 וגם זה שנערך בבני 12-15, אם תוכלו להכווין לנקודה שבה חיסון פייזר הוכיח מניעת הדבקה או מניעת מחלה קשה בילדים https://t.co/C8eLsmpWo8 https://t.co/Foijc1l8Uc
@sylv_lau @raoult_didier Nous confirmons que ce vaccin induit une réponse immune qui protège, efficacement et sans dommage, y compris chez les jeunes. La seule limite concerne la variabilité antigénique des virus respiratoires à ARN qui oblige à en changer la composition https://t.co/L83HVAaCIO
@Hetismijmike @Me_xNL @JeroenPols Hier, alvast de studie onder adolescenten: https://t.co/UwmuwnJmLn En die onder kinderen vanaf 5 jaar: https://t.co/f5nuBsDKaX En op basis daarvan werd de goedkeuring uitgebreid voor deze doelgroepen.
RT @_Prometeusz_: @Clucky92864053 Re: BNT162b2. "[T]here were no vaccine-related serious adverse events....". Then who is Maddie De Garay?…
@Clucky92864053 Re: BNT162b2. "[T]here were no vaccine-related serious adverse events....". Then who is Maddie De Garay? ( https://t.co/4JupM2BZSn ) https://t.co/KBsXLa7P8C https://t.co/EoGktAqUYA
@deSieteColores @sjs856 @SeivwrightTrudy https://t.co/lX9iNeEH3g
@laurentmel13 @SangD_Encre @JohanneBouquet @RogezVeronique Tu peux répéter que Pfizer n'a pas testé ces vaccins sur les enfants s'il te plaît. Je veux vérifier un truc. https://t.co/8udct1en0y https://t.co/A64BeivrsL
@DesmondDrake12 @Benurse6 @eglem1 @Mag0min0gaM @TD8949 @DocAmine_ https://t.co/G1GMfQCe0b
@Volksverpetzer Beim Quellenprüfen ist mir folgendes aufgefallen: "<a href="https://t.co/vh4hwcAN3T">Formica 2021</a>; <a href="https://t.co/vh4hwcAN3T">Frenck 2021</a>" 2x gleiche Quelle, denke Frenck sollte https://t.co/T099YgXSEP sein
@caz_sampson @profnfenton @ABridgen IF : "Yes this is normal for clinical trials - you provide evidence to show the 2 groups are well matched at baseline." then where is it? Please direct same criticism to authors of this study: https://t.co/Dbfyv7gDdV Where is comparison? were the groups matched? How do you know?
@caz_sampson @profnfenton @ABridgen Point those cofounders in adolescents i.e. here? https://t.co/Dbfyv7gDdV
@RB84509962 @CaulfieldTim @factaotearoa @NBCNews https://t.co/CKfs7Imx0H https://t.co/P7pAiKP0P5 https://t.co/yhyyJPLdLO Ongoing https://t.co/hyyWnjgRTb
@CloudPristine @Monstercoyliar @NewSeasonsSpa @handmadekathy @FrankDElia7 @TruthTwt @iXeno @cappsie @jayjoseph22 @crabb_vicki @rightwingblack2 @FUDyou2 @SkepticalMutant @IainMulady @doritmi @JCDeardeuff @Izzitreally2 @Jccalmond2 @krebiozen @TweetOfSteiner @Augusti03401363 @ianfmusgrave @BlueLionBlog @thisisnothappen @natedoromal @TheFrankmanMN @Blackcatprowl3 @isa_picard @HawkInATX @VVDeingott @foofdawg @4thEchelon22 @TinFoilAwards @ktibus @F250Roush @Juanita87722370 @MsTrixter @Kathmarval @mrhawkes @BGLTHMND @ChrisJohnsonMD @ThomasHarrigan8 @BigBruce1972 @keithccurtis @John010708 @lewbloch @somethinsomethi @lizditz published.... https://t.co/zWigSagpEA
Then who is #MaddiedeGaray? "Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents" ( https://t.co/4JupM2CxHV ) https://t.co/p9Thx0Br18
RT @_Prometeusz_: Then who is #MaddieDeGaray? ( https://t.co/4JupM2BZSn ) #COVID19 #SARSCoV2 #VaccineSideEffects h/t @sonia_elijah: https:/…
@zet_mood @ben_ben_fr Deuxième etude : https://t.co/X0kWqmO9CP Financée par Pfizer et BioNTech Ne concerne que les 12-15 ans 1100 adolescents vaccinés Conclut en se félicitant que les effets à court terme sont peu intenses, et qu'il y a eu zéro infection chez les vaccinnés (ont ils été exposés ?)
@calotonterias @NatxFrancisco @InesSempere @Farmaenfurecida Si no aceptas todo esto es porque estás vendido. Porque pruebas hay de sobra. https://t.co/agFdbyFcJI https://t.co/AHIp8fRzSd https://t.co/U29B6UVHFL https://t.co/kCIROd4pqE https://t.co/I2fYYreYVw
@Bonbonhamilton @ProudMO98549608 @DrJamesOlsson #2 https://t.co/mtX7eQv77M
RT @GValeau: @BessonFlorent2 @religionnaire @Rublev18 @ldd64 Tu penses pas que tu aurais pu trouver les infos tout seul ? https://t.co/RWT…
@BessonFlorent2 @religionnaire @Rublev18 @ldd64 Tu penses pas que tu aurais pu trouver les infos tout seul ? https://t.co/RWTruu4fPL https://t.co/XLj2v101as https://t.co/JPR8f4l4nf https://t.co/ah8LxvO2bY
@CHSdoctor @JHowardBrainMD Obviously, if you want to minimize the risk of rare side effects showing up in a trial, you choose as small a sample size as you can get away with. The FDA did let them get away with it. https://t.co/KxUDpqnnaa
@dedilu08 @Martaalasocho @Rodolfo67251983 https://t.co/cFWCfzu127
Then who is #MaddieDeGaray? ( https://t.co/4JupM2BZSn ) #COVID19 #SARSCoV2 #VaccineSideEffects h/t @sonia_elijah: https://t.co/iuZiHvlejv https://t.co/TW0OkcPzKO https://t.co/KBsXLa7P8C
24/stop the shots ...스파이크단백질에 의해 생성된 혈중항체농도 측정한 것 뿐입니다. 그러나 이 항체군은 호흡기계로 인한 감염을 전혀 막지 못합니다. 위 실험 연구에서 보여준 사실은 코로나 백신 접종이 어린이에게 주는 득이 사실상 없다는 사실입니다. (계속) https://t.co/LjG8JPpgB4
@tomomiheiwa @b5sIyAlzpefcXRS @nishiurah https://t.co/otO7bHJWGy https://t.co/ZVL6ONldaV このあたりでよろしいですか?
@ecozdence Hanımefendi siz bilmiyor olabilirsiniz lakin etiket onayı değildir bu :) CDC(YİNE DEVLET KURUMU) aşı yapılmasını onaylıyor buradaki Ayrıca attığınız linkte https://t.co/2NZw7lLQLx Bunu gördünüz mü? EMA'nın da onayını atarım isterseniz yetkilendirilmiştir diye
@larbalette1 @Christo90370259 @rosewood2019 @AnarchroniqueS @decoder_l @jenyhart2 @GuisonJerome @DocAmine_ @mauriceIarm2022 1) c'est pas la question. Vous changez encore 1 fois de sujet. 2) la vaccination chez les enfants reste efficace contre les formes symptomatiques du Covid et sûre : https://t.co/A64BeivrsL
@BrydenBradley @RiggerRudolph @RealGeorgeWebb1 @EduEngineer @Unbekoming @RenzTom @TessaMakesLove @JuliusRuechel @RemnantMd @DrVladZelenko @Storiesofinjury As we head into the VRBPAC meeting for children a couple reminders. They approved Pfizer for children and adolescents based on the results of 2200 participants in both the 5-11 and 12-15 year old cohorts. / https://t.co/IjRBqQYego https://t.co/T95e8jyyGa
@Dalmane15 Sorry, I jumped from the 5-11 trials to the adult trials. There are only 2260 in this Pfizer trial for 12-15 year olds. https://t.co/IjRBqQYego
@5948374739395d @MiguelM66102418 @trucmuc28502451 @WhiteRabbit969 @rahl_paul @Concept70785298 @DocArnica Non La vaccination est sûre et efficace contre le Covid. La balance bénéfice/risque est en faveur de la vaccination puisque moins de risque de forme grave ET sécurité de l'injection. Vous répétez encore et toujours des fakenews https://t.co/A64BeivrsL
@5948374739395d @MiguelM66102418 @trucmuc28502451 @WhiteRabbit969 @rahl_paul @Concept70785298 @DocArnica Toujours pas
@Sandra82824997 @ONRedaktion @doc_ecmo Für Kinder: https://t.co/qyNpaNEzSh https://t.co/30HqoxowIk STIKO und sonstige Impfkomissionen entscheiden sowas auch natürlich nur nach Belieben und pers. Gusto.
@AntoinetteColby @flolaur71 @MontvalSarth @LouhansT @RGaugry @CarolineFiat54 @olivierveran Vous faites semblant de ne pas comprendre. Ouvrez les yeux une bonne fois pour toute La vaccination est efficace car elle diminue le risque de formes graves et la mortalité du Covid. Y compris chez les jeunes. https://t.co/A64BeivrsL
@maaktnietuit20 [2/3] 3. Wetenschappelijke studie naar de veiligheid én effectiviteit van de mRNA vaccins: https://t.co/TmGSzEN3Sg. 4. Veiligheid en effectiviteit van de coronavaccins in adolescenten: https://t.co/Q9jMDJeABd
@nranranranran @RanRoi777 @nirdinur @ravitshani1 @BoazHorovitz https://t.co/lVROf8Db6x https://t.co/3upVLGENRV https://t.co/IvOCNyJZKv
RT @laworfiction: 1/ PFIZER’s REPORT: In their trial of just 1,131 children age 12 to 15: life threatening events 0.1% diarrhoea 8% vomit…
RT @laworfiction: 1/ PFIZER’s REPORT: In their trial of just 1,131 children age 12 to 15: life threatening events 0.1% diarrhoea 8% vomit…
@payLiina1984 @FortitudeDei @Johan_Paukahti @TiiaTanninen @OKuokka @takapirulainen @OssiTiihonen @THLorg @HNohynek THL KRAR https://t.co/1KtzmxxP1W Eli nämä: https://t.co/Pqtzd2NqXq jossa käytetty NCT04649151 https://t.co/mxb26082tl ja tässä taas NCT04816643 Ks. mm. mun blogista tarkemmin. https://t.co/hnD6yXvkKu
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @InmunoUnicornio: Fuentes ⛲ 1️⃣https://t.co/Un7TMGQYk7 2️⃣https://t.co/gobjsK8vGy 3️⃣https://t.co/FmOnmuokrM 4️⃣ https://t.co/nd40GiOD…
RT @InmunoUnicornio: Fuentes ⛲ 1️⃣https://t.co/Un7TMGQYk7 2️⃣https://t.co/gobjsK8vGy 3️⃣https://t.co/FmOnmuokrM 4️⃣ https://t.co/nd40GiOD…
RT @InmunoUnicornio: Fuentes ⛲ 1️⃣https://t.co/Un7TMGQYk7 2️⃣https://t.co/gobjsK8vGy 3️⃣https://t.co/FmOnmuokrM 4️⃣ https://t.co/nd40GiOD…
RT @InmunoUnicornio: Fuentes ⛲ 1️⃣https://t.co/Un7TMGQYk7 2️⃣https://t.co/gobjsK8vGy 3️⃣https://t.co/FmOnmuokrM 4️⃣ https://t.co/nd40GiOD…
Fuentes ⛲ 1️⃣https://t.co/Un7TMGQYk7 2️⃣https://t.co/gobjsK8vGy 3️⃣https://t.co/FmOnmuokrM 4️⃣ https://t.co/nd40GiODBA 5️⃣https://t.co/C9GNDclCgA 11/11
@Asteroidix1 @RealMikeTyson22 @ArchivGerdK10 @sabi_ri @Felicea @SchwesterAngela @cdm2311 @DrNathanCole @WahnSager @danny_mst @NoDumbAlliance @Stormageddon666 @dhans085 @ZuckerZucker3 @MoldenUniverse @auf_en @BMauschen @C_Siemering @EdzardErnst @humbughund @NatalieGrams @PaulaPasst @Musician1980 @MgchaconMaria @Bates14121 @trottelei @SapiensWell @PeterGeimpft @Fotobiene @HolgerHamburgo @amigo_astro @JaneDoeOriginal @Susanne45217800 @JenniferHapke @Susannchen01
@MattRandolphLee @stevereed84 Great, so you acknowledge there is some contribution. Now let’s check other datasets to see if your claim of “vaccinated children are more likely to die” is correct. It doesn’t hold up… https://t.co/Tbwbpr0Qq2 https://t.co/M76GHMrtIC https://t.co/1GyWgAlVdt
@IPiikki Blogista ja Fb:sta löytyy pidemmin avattuna (FI&ENG): KRAR (ja EMA:n) raportin (hyväksynnän&suos) "turvallisuus" siis viittaa: https://t.co/Pqtzd2NqXq -> NCT04649151 https://t.co/mxb26082tl -> NCT04816643 Which BOTH are part of the Ventavia scandal (BMJ 2.11.2021, 375:n2635).
@DrLeanaWen @wolfblitzer Comment this: https://t.co/zsLslP80AM https://t.co/EcYPNPwRQq https://t.co/KAiwSlC4IF https://t.co/YTEGFKgmy0 Compare risk in table1 day14 cumulative https://t.co/Q5l4aCgojr and figure 2 c/d in https://t.co/Dbfyv7xGfV
@TimeVoyageur @WSide75 @olivierveran Tu me sors un screen d'un article de presse, je te sors une meta-analyse qui dit texto que même chez les 12-15 ans y'a un bénéfice On a pas le même sérieux, c'est tout. https://t.co/6mvbFXvkO1 https://t.co/fKTSajNBV9
https://t.co/x4bOkWU5JE [3] Tous sont employés de Pfizer ou en lien d'intérêt avec Pfizer. https://t.co/5O6XJkYfr0 https://t.co/o4jWVEXa4p [4] Tous sont employés de Biontech ou Pfizer, ou en lien d'intérêt avec Biontech ou Pfizer. https://t.co/fOhmgJHtvc 3/7
@GeffWestcoast Et je te respecte pour ça. Concernant les - de 50 ans c’est faux, 2 études qui disent le contraire et ne te permettent pas de faire une réflexion générale « C’est avéré scientifiquement »: - https://t.co/hOxYEu7C9Q - https://t.co/wMDPaKgyUo
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
@Er_Miniaba @TioTxapas @fmorenotrapote @BeatrizTalegon Hay estudios específicos en adolescentes https://t.co/2hEZVp2fur y población pediátrica https://t.co/bKhsOwryds
@der_eike23 @zideshowbob @mondschaf23 Diese Studie von BioNTech/Pfizer war die Grundlage für die bedingte Zulassung. Das endgültige Ergebnis soll im Mai 2023 vorliegen. Die vorläufigen finden Sie, wenn sie den Links unten auf der Seite folgen. Hier der zweite Link mit den 95%: https://t.co/c5xizGQdKC
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
@Stratos_Mactra @jordanbpeterson If drug companies could be trusted to not dissemble then perhaps you might have a point. Can you find anything in the NEJM report of the 12-15 year old trials that looks anything lie Maddie de Garay, cause I sure as hell can't: https://t.co/pkeskPPqG7
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @laworfiction: 1/ PFIZER’s REPORT: In their trial of just 1,131 children age 12 to 15: life threatening events 0.1% diarrhoea 8% vomit…
RT @JamesfWells: One 14yr old (1,131 sample) was removed due to a vaccine related 'life threatening event', thats 1 in 10k (rounded) Table…
Next RCT in 12-15y: 2260 participants. Tolerability, immunogenicity & efficacy assessed. Sample size is 5% of the 16+y trial. Rare side effects found after introduction. This was unanticipated & mechanism unknown 3/ https://t.co/ro4Lhzuhfc
@EsquireErrant @carrr_losss @fleshys_sister @razibkhan 2260 yes. https://t.co/76RU8yk8pL Which is already more than enough to establish that it is vastly safer than the virus they're vaccinated against. https://t.co/VsPJy5xyv8
@Marky_Tic @edyong209 Children with previous SCV2 infection were excluded from the trial during recruitment. https://t.co/mpwD0uZO2j
RT @mahesh_shenai: 3c/ Total AEs are difficult to quantify, because it varies and covers a large spectrum. For all related AEs (mostly mild…
@sanchezacero @Dr_Pilgrim @Licualopodo @Hjorvik @Buenrollo13 @Vigo_libre @Mirambella @vinyes71 @s4wek @Desobediencia00 @cosmonau74 @xiquitinx @CancerIntegral @KAkosombo @Mark__IV @krittikoh @Dictatriz Aquí tienes de adolescentes. Algo más? https://t.co/qOTSYoZ7pF
@petiteli5 Acá, algunos estudios en niños y adolescentes: https://t.co/6KZ9iQEyB2 https://t.co/2CUgiRwSyH https://t.co/lpDh9GRjhx https://t.co/xGkkV2CShv
3c/ Total AEs are difficult to quantify, because it varies and covers a large spectrum. For all related AEs (mostly mild/moderate), we can take from the Pfizer 12-15 yo trial (Frenck Jr., NEJM) = ~3% (https://t.co/libpn41tkE ) https://t.co/orxk33aMeN
RT @UKFreedomProj: Funded by BioNTech and Pfizer. The BioNTech and Pfizer BNT162b2 vax in 12-to-15-year-old recipients had a favourable sa…
Funded by BioNTech and Pfizer. The BioNTech and Pfizer BNT162b2 vax in 12-to-15-year-old recipients had a favourable safety profile, produced a greater immune response than in young adults, and was highly effective against C-19. NOTHING TO SEE HERE https://t.co/LAwDVDQspI https://t.co/RNTSLAkw1Z
“Noninferiority of the immune response to BNT162b2 in 12-to-15-year-old participants as compared with that in 16-to-25-year-old participants was an immunogenicity objective” / “Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Ado…” https://t.co/93YiyuIydI
"… (vaccine efficacy, 75%; 95% CI, 7.6 to 95.5) (Table S3). No cases of severe Covid-19 were observed in this age cohort." https://t.co/V8Z0Y4vblE
This paper looks like the journal version of the data in the press release - again, it tells us about the value of two doses, not the value of a single dose. https://t.co/2A7Cx7fuGU
RT @ElGatoyLaCaja: Los resultados de los ensayos de Pfizer-Biontech para mayores de 12 años se pueden leer en https://t.co/dQXY2gWDXU. Un…
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents https://t.co/SN1kKoFYq9
@JumaLazzati @JSchmukler https://t.co/W20CyT17gQ
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
@TonyAda89223627 https://t.co/mpwD0uZO2j
@EWayedd @Sandyboots2020 The protection is very good. https://t.co/mpwD0uZO2j
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @ElGatoyLaCaja: Los resultados de los ensayos de Pfizer-Biontech para mayores de 12 años se pueden leer en https://t.co/dQXY2gWDXU. Un…
RT @ElGatoyLaCaja: Los resultados de los ensayos de Pfizer-Biontech para mayores de 12 años se pueden leer en https://t.co/dQXY2gWDXU. Un…
Los resultados de los ensayos de Pfizer-Biontech para mayores de 12 años se pueden leer en https://t.co/dQXY2gWDXU. Un reciente comunicado de prensa del laboratorio asegura que también es segura para niñes de 5 a 12 años: https://t.co/jjAftduiLZ
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @Debunk_the_Funk: Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescent…
Well that’s a complete lie. No deaths were reported in Pfizer and Moderna COVID vaccine clinical trials for adolescents. https://t.co/vuGgy5pQbA https://t.co/sVgCsXixp6 Meanwhile, hospitalization of children due to COVID is rising significantly. https://t.co/bhM3ssLjPO https://t.co/6m9YhrFf9i
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
@elp156 @cmandarano @ASlavitt https://t.co/awjPDgfBt6
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @JSchmukler: 9/ Se necesitan estudios CLÍNICOS, con un número mucho mayor de participantes y con un seguimiento más prolongado. Comparon…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
@tobiaskingco @SandroDemaio This study Tobias, though research papers are a hard read & this alone can put ppl off. Finds: there were no vaccine-related serious adverse events and few overall severe adverse events. Sample size=1131 12-15yo https://t.co/8n0x62glBZ
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
@UltraB_ @XawierRon @BobLeCentriste https://t.co/IMWVaGz5AR et puisque vous le demandez: voici. New England.
@Kakkooooo1 @riverad84221212 @PorunChileDigno @itajuschile https://t.co/YAULVTweSj
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @GerardHorta: L'únic estudi científic publicat sobre "seguretat" en adolescents dels productes gènics experimentals en voga és aquest. L…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
RT @familiade3hijos: 15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las…
15) A 20/09/21 hay 1 solo estudio científico publicado (https://t.co/bfzETb9Fpt) que haya evaluado la seguridad de las vacunas en adolescentes. (https://t.co/XPySexlaCc). Excluyeron aquellos con problemas de salud, alergias a vacunas, y los expuestos al virus. ¿Entonces?
RT @GerardHorta: L'únic estudi científic publicat sobre "seguretat" en adolescents dels productes gènics experimentals en voga és aquest. L…
L'únic estudi científic publicat sobre "seguretat" en adolescents dels productes gènics experimentals en voga és aquest. L'únic. La Dra. Acevedo Whitehouse escriu (imatge de sota de tot): https://t.co/VnLy2FUW1F https://t.co/jWVgguARLl
RT @lumafelic: @JanainaDoBrasil Comé qui é? Começa lendo esse https://t.co/CAcEn1SljL
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents https://t.co/h8wtHKgeJp
@JanainaDoBrasil Digitei "teenager vaccine covid studies" no google e na primeira página eu achei isso. De nada. https://t.co/KEjRz8bKAT
@victtor_d2 @BernardoMF https://t.co/CnNGHauf5M https://t.co/OnSULKeIZC https://t.co/aFoCeLwoPy alguns que achei…
Una búsqueda de la literatura científica muestra que al día de hoy (16/09/21), hay un solo estudio científico publicado (https://t.co/LjQyZanpHd) que haya evaluado la seguridad de las vacunas en adolescentes. (sigue)
@quesahco @Vem2023 @PrefSalvador Que mentira descarada do ministério da saúde. Inclusive, não existe estudo dizendo que é bom pra Comorbidades e pra outros não. Só existe estudo mostrando que não só é eficaz e seguro, como é MAIS EFICAZ que em adultos. https://t.co/DDwYJYre0b
@PopCatalin @varbmos @truth_tesla @WR4NYGov @MichaelVSmith3 @AngelNDevil2 @JohnnaCrider1 @NuovaRealta @ICannot_Enough @ElonsBrain @enn_nafnlaus https://t.co/tdcUbjyaJe Here is one.
@MacaneiroV @JanainaDoBrasil Olha aqui um estudo conclusivo que não existe: “Conclusions: The BNT162b2 vaccine in 12-to-15-year-old recipients had a favorable safety profile, produced a greater immune response than in young adults, and was highly effective against Covid-19.” https://t.co/fVGKLu8Csy
RT @lumafelic: @JanainaDoBrasil Comé qui é? Começa lendo esse https://t.co/CAcEn1SljL
RT @lumafelic: @JanainaDoBrasil Comé qui é? Começa lendo esse https://t.co/CAcEn1SljL
@JanainaDoBrasil Comé qui é? Começa lendo esse https://t.co/CAcEn1SljL
@KingRabbit78 @tbernard1979 @PotusLisa @AngeGuen @vvantighem @BFMTV @franceinfo Etude 2 et 3 : c'est les études pour les moins de 12 ans pour qui le vaccin n'est PAS autorisé... L'étude 1: c'est l'étude dont le résultat sur la sécu est déjà publié ici : https://t.co/9SF4EUWPYY. CCL: comme pour les adultes il ne manque que la partie "efficacité à long terme" https://t.co/QsAcZyl0i7
@KingRabbit78 @tbernard1979 @PotusLisa @AngeGuen @vvantighem @BFMTV @franceinfo Vous pouvez sourcer votre "déclaration" de pfizer et de la FDA ? Au passage pour le bénéfice risque sur les 12-18 on a toutes les infos de l'étude phase 3 (tout ce qui manque c'est la persistance de l'immunité à long terme), publiée ici https://t.co/9SF4EUWPYY
RT @shazwan_sazali: @gwasteady @mykamar77 @Xxfariz1 https://t.co/W9CqofFjaP
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents https://t.co/1qKkzS6Ub2
https://t.co/W9CqofFjaP
@gwasteady @mykamar77 @Xxfariz1 https://t.co/W9CqofFjaP
2021/7/15 出版分 twitterでバズった論文 全分野 Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents https://t.co/MyV3um9DLX 7189 tweets
RT @Jaime_Culebras: @MostTuitero @SUgayos @salva_iborra Aquí el estudio. Léelo con calma (y anímate a leer muchos otros sobre epidemiologí…
#論文紹介 ファイザーワクチンの12-15歳への効果をまとめた論文が出ました！ ✅2260人規模のＲＣＴでワクチン関連の有害事象は無し ✅人数が少ないというのもありますが、ワクチンの効果はなんと100% ✅有効性の95%信頼区間は75-100% 接種年齢の拡大は問題なさそうです
@MostTuitero @SUgayos @salva_iborra Aquí el estudio. Léelo con calma (y anímate a leer muchos otros sobre epidemiología) antes de llamar puta basura a quienes hacen ciencia para mantenerte a salvo... https://t.co/hT3FX3yjaS
2021/5/27 出版分 twitterでバズった論文 全分野 Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents https://t.co/w4JxBz2phh Tweets: 4487
Phizerワクチンは12～15歳でも有効（n=2260。効果100%、95%CI 75.3-100）かつ安全 https://t.co/ELujKw3TlW